Department of Medicine and Surgery, Università di Parma, Parma, Italy.
Division of Endocrinology and Metabolic Diseases, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Diabetes Metab Res Rev. 2023 Nov;39(8):e3708. doi: 10.1002/dmrr.3708. Epub 2023 Aug 13.
To assess the efficacy of a structured educational intervention for health professionals on the appropriateness of inpatient diabetes care and on some clinical outcomes in hospitalised subjects.
A multicentre (6 regional hospitals) cluster-randomized (2:1) two parallel-group pragmatic intervention trials, as a part of the GOVEPAZ study, was conducted in three clinical settings, that is, Internal Medicine, Surgery and Intensive Care. Intervention consisted of a 2-month structured education of clinical staff to inpatient diabetes care. Twelve wards - 2 for each hospital - and 6 wards - 1 for each hospital - were randomized to usual care and to the intervention arm, respectively. Consecutively hospitalised diabetic subjects (n = 524, age 74 ± 14 years, 57% males, median HbA1C 57 mmol/mol) were included. The clinical appropriateness of inpatient diabetes management was assessed by a previously validated multi-domain performance score (PS). Clinical outcomes included hypoglycemia, glucose control biomarkers, clinical conditions at discharge and inpatient mortality rate.
A numerically, but not statistically significant, higher PS (+0.94; 95% C.I.: -0.53 - +2.4) was achieved in the intervention than in the usual care wards. Hypoglycemias (p = 0.32), glucose control (p = 0.89) and survival rates (p = 0.71) were similar in the two experimental arms. Plasma glucose on admission (OR = 1.52 per 1 SD; C.I. 1.07-2.17; p = 0.021) and the number of hypoglycemic events per patient (OR = 1.55 per 1 SD; C.I.:1.11-2.16; p = 0.011) were independently associated with the inpatient mortality rate.
Structured education of the clinical staff failed to improve the inpatient appropriateness of diabetes care or clinical outcomes. In-hospital hypoglycemia was confirmed to be an independent indicator of death risk.
评估针对住院患者糖尿病治疗的适宜性以及住院患者部分临床结局,为卫生专业人员提供结构化教育干预的效果。
该研究为 GOVEPAZ 研究的一部分,采用多中心(6 家地区医院)集群随机(2:1)两平行组实用干预试验设计,在三个临床科室(内科、外科和重症监护病房)开展。干预措施包括对临床医护人员进行为期 2 个月的住院糖尿病治疗结构化教育。12 个病房(每家医院各 2 个)和 6 个病房(每家医院各 1 个)分别被随机分配至常规护理组和干预组。连续纳入 524 例住院糖尿病患者(年龄 74±14 岁,57%为男性,中位糖化血红蛋白 57mmol/mol)。通过先前验证的多领域表现评分(PS)评估住院患者糖尿病管理的临床适宜性。临床结局包括低血糖、血糖控制生物标志物、出院时临床情况和住院死亡率。
干预组的 PS 评分(PS 评分增加 0.94;95%CI:-0.53-2.4)虽呈上升趋势,但无统计学意义。两组的低血糖(p=0.32)、血糖控制(p=0.89)和生存率(p=0.71)相似。入院时血糖(OR=1.52/1SD;95%CI:1.07-2.17;p=0.021)和每位患者低血糖事件次数(OR=1.55/1SD;95%CI:1.11-2.16;p=0.011)与住院死亡率独立相关。
对临床医护人员进行结构化教育未能改善住院患者糖尿病治疗的适宜性或临床结局。住院期间发生低血糖被确认为死亡风险的独立指标。